July 01, 2016   DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, today announced it has entered into an agreement with Seikagaku Corporation to continue distributing SUPARTZ FX™ in the US after the current distribution agreement expires in May 2017. Under terms of this extension, Bioventus will continue to distribute SUPARTZ FX in the […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone